Ferric Isomaltoside IH Spec
- Product Name : Ferric Isomaltoside
- CAS : 1370654-58-2
- Pharmaceutical Grade : IH Spec
- Therapeutic Category : Iron injection (IV)
Global Calcium is one of the leading manufacturers and exporters of Ferric Isomaltoside CAS no. 1370654-58-2, API, (Active Pharmaceutical Ingredient). We support the customers with exhaustive documentation. As a USDMF & EU-GMP certified global company and an established hallmark for pharmaceutical standards, Global Calcium has stood the test of time since its inception in 1979.
As manufacturer of Ferric Isomaltoside we hereby state the following facts about the drug:
Indications for Use
Iron Deficiency Anemia (IDA): This drug is indicated for the treatment of iron deficiency anemia in adult patients who have experienced intolerance to oral iron preparations or
insufficient clinical response to orally administered iron. It increases the reticulocyte count and ultimately increases hemoglobin, treating iron deficiency anemia and its various symptoms.
Kidney disease: It is also indicated for patients with non-hemodialysis dependent chronic kidney disease
Ferric Isomaltoside drug is a complex made of iron (III) hydroxide and derisomaltose, which is an iron carbohydrate oligosaccharide that works to releases iron. The released iron then binds to the transport protein, transferrin, and is taken to erythroid precursor cells for incorporation into the haemoglobin molecule.
Global Calcium is a leading manufacturer of this drug. We manufacture this pharmaceutical drug and make it available to domestic and overseas market